tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Jazz Pharmaceuticals initiated with an Overweight at Barclays
PremiumThe FlyJazz Pharmaceuticals initiated with an Overweight at Barclays
12d ago
Jazz Pharmaceuticals price target raised to $226 from $225 at Morgan Stanley
Premium
The Fly
Jazz Pharmaceuticals price target raised to $226 from $225 at Morgan Stanley
14d ago
Jazz Pharmaceuticals price target raised to $255 from $210 at Deutsche Bank
Premium
The Fly
Jazz Pharmaceuticals price target raised to $255 from $210 at Deutsche Bank
14d ago
Jazz Pharmaceuticals sees FY26 revenue $4.25B-$4.5B, consensus $4.5B
PremiumThe FlyJazz Pharmaceuticals sees FY26 revenue $4.25B-$4.5B, consensus $4.5B
14d ago
JAZZ Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
JAZZ Earnings this Week: How Will it Perform?
17d ago
ALX Oncology announces new data from Phase 1b/2 trial of evorpacept, Ziihera
Premium
The Fly
ALX Oncology announces new data from Phase 1b/2 trial of evorpacept, Ziihera
1M ago
BofA ups Jazz Pharmaceuticals price target, says selloff ‘unwarranted’
PremiumThe FlyBofA ups Jazz Pharmaceuticals price target, says selloff ‘unwarranted’
2M ago
Closing Bell Movers: AXT Inc. slips after cutting Q4 revenue guidance
Premium
The Fly
Closing Bell Movers: AXT Inc. slips after cutting Q4 revenue guidance
2M ago
Jazz Pharmaceuticals names Thomas Riga as Chief Business Officer
Premium
The Fly
Jazz Pharmaceuticals names Thomas Riga as Chief Business Officer
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100